Díaz-Ortega José Luis, Durón-Andino Regina, Zuñiga-Ocampo Cesar Omar, Rios-Castillo José Gerardo, Román-Castro Eva, González-Ramírez Luis Humberto, Aguilar-Villaseñor José Manasés, Jacobo-Ramírez María Guadalupe
Centro Nacional para la Salud de la Infancia y la Adolescencia Ciudad de México México Centro Nacional para la Salud de la Infancia y la Adolescencia, Ciudad de México, México.
Organización Panamericana de la Salud Ciudad de México México Organización Panamericana de la Salud, Ciudad de México, México.
Rev Panam Salud Publica. 2024 Dec 16;48:e111. doi: 10.26633/RPSP.2024.111. eCollection 2024.
To describe Mexico's experience of a high-quality follow-up vaccination campaign against measles and rubella in children aged 1 to 4 years, and actions taken to recover the coverage of other biologics during the COVID-19 health emergency.
Use of a microplanning tool in the design and implementation of a follow-up campaign to protect 8 604 781 girls and boys aged 1 to 4 years and to complete other vaccination schedules, followed by the implementation of rapid vaccination monitoring.
A total of 8 026 184 doses of MR vaccine were administered to children aged 1 to 4 years, with a coverage rate of 93.3%. In addition, 3 058 201 doses of MMR vaccine and 2 361 021 doses of hexavalent vaccine were administered. Rapid vaccination monitoring was carried out 78 times in selected municipalities in the country, where 30% (18 692) of 62 308 children aged 1-4 years contacted were found to be unvaccinated. The reasons for not vaccinating were "not knowing it was necessary" (28.5%), "not having time" (21.2%), "other reasons" (mainly fear of getting sick from COVID-19 in health centers) (12.9%), "believing they had received two doses of MMR vaccine" (9.1%), or "not knowing where to get vaccinated" (8.7%); 19.6% did not respond.
The high-quality vaccination campaign was successful, favoring the sustainability of measles, rubella, and polio elimination, as well as the control of other vaccine-preventable diseases, and demonstrating the relevance of microplanning.
描述墨西哥针对1至4岁儿童开展的高质量麻疹和风疹后续疫苗接种运动的经验,以及在新冠疫情卫生紧急状态期间为恢复其他生物制品接种覆盖率所采取的行动。
在设计和实施一项后续运动时使用微观规划工具,以保护8604781名1至4岁的女童和男童并完成其他疫苗接种计划,随后开展快速疫苗接种监测。
共向1至4岁儿童接种了8026184剂麻腮疫苗,接种率为93.3%。此外,还接种了3058201剂麻腮风疫苗和2361021剂六联疫苗。在该国选定的市进行了78次快速疫苗接种监测,在62308名接受接触的1至4岁儿童中,发现30%(18692名)未接种疫苗。未接种疫苗的原因包括“不知道有必要接种”(28.5%)、“没有时间”(21.2%)、“其他原因”(主要是担心在医疗中心感染新冠病毒)(12.9%)、“认为已接种两剂麻腮风疫苗”(9.1%)或“不知道在哪里接种”(8.7%);19.6%未作出回应。
高质量的疫苗接种运动取得了成功,有利于麻疹、风疹和脊髓灰质炎消除工作的可持续性,以及其他疫苗可预防疾病的控制,并证明了微观规划的相关性。